Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. Leukemia 2008 Jun;22(6):1295-8

Date

12/07/2007

Pubmed ID

18059483

DOI

10.1038/sj.leu.2405054

Scopus ID

2-s2.0-45149121653 (requires institutional sign-in at Scopus site)   26 Citations

Author List

Atallah E, Nussenzveig R, Yin CC, Bueso-Ramos C, Tam C, Manshouri T, Pierce S, Kantarjian H, Verstovsek S

Author

Ehab L. Atallah MD Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Aged, 80 and over
Anemia, Refractory
Anemia, Sideroblastic
Female
Humans
Janus Kinase 2
Male
Middle Aged
Myelodysplastic Syndromes
Myeloproliferative Disorders
Point Mutation
Prognosis
Survival Rate
Thrombocytosis
World Health Organization